NasdaqGS - Nasdaq Real Time Price USD

Black Diamond Therapeutics, Inc. (BDTX)

1.9500
+0.0200
+(1.04%)
At close: May 16 at 4:00:01 PM EDT
1.9100
-0.04
(-2.05%)
After hours: May 16 at 7:49:31 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
70,000
0
0
0
0
Operating Expense
74,005
78,781
86,460
92,828
126,872
Operating Income
-4,005
-78,781
-86,460
-92,828
-126,872
Net Non Operating Interest Income Expense
2,140
2,182
1,924
2,031
3,464
Other Income Expense
6,956
6,923
2,094
-372
-2,188
Pretax Income
5,091
-69,676
-82,442
-91,169
-125,596
Net Income Common Stockholders
5,091
-69,676
-82,442
-91,169
-125,596
Diluted NI Available to Com Stockholders
5,091
-69,676
-82,442
-91,169
-125,596
Basic EPS
0.08
-1.27
-1.88
-2.52
-3.47
Diluted EPS
0.06
-1.27
-1.88
-2.52
-3.47
Basic Average Shares
56,242.1080
55,028.3710
43,954.6490
36,229.8090
36,189.0020
Diluted Average Shares
56,494.4340
55,028.3710
43,954.6490
36,229.8090
36,189.0020
Total Operating Income as Reported
-4,005
-78,781
-86,460
-92,828
-126,872
Total Expenses
74,005
78,781
86,460
92,828
126,872
Net Income from Continuing & Discontinued Operation
5,091
-69,676
-82,442
-91,169
-125,596
Normalized Income
5,091
-69,676
-82,442
-93,401
-125,596
Interest Income
2,140
2,182
1,924
2,031
3,464
Interest Expense
--
--
--
--
0
Net Interest Income
2,140
2,182
1,924
2,031
3,464
EBIT
-4,005
-78,781
-86,460
-92,828
-126,872
EBITDA
-3,661
-78,438
-86,023
-92,320
-126,667
Reconciled Depreciation
344
343
437
508
205
Net Income from Continuing Operation Net Minority Interest
5,091
-69,676
-82,442
-91,169
-125,596
Total Unusual Items Excluding Goodwill
--
--
0
2,232
0
Total Unusual Items
--
--
0
2,232
0
Normalized EBITDA
-3,661
-78,438
-86,023
-94,552
-126,667
Tax Rate for Calcs
0.0002
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 1/31/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

XLO Xilio Therapeutics, Inc.
0.8594
+7.42%
 
INMB INmune Bio, Inc.
7.86
+7.82%
 
CABA Cabaletta Bio, Inc.
2.0300
+12.15%
 
KTTA Pasithea Therapeutics Corp.
0.9560
+11.09%
 
ABP Abpro Corporation
0.2300
-13.24%
 
CTMX CytomX Therapeutics, Inc.
2.0300
+1.50%
 
CRVS Corvus Pharmaceuticals, Inc.
3.6100
+0.84%
 
ENSC Ensysce Biosciences, Inc.
2.3400
+9.35%
 
CNSP CNS Pharmaceuticals, Inc.
1.2800
+1.59%
 
NCNA NuCana plc
0.0438
-17.98%